Estée Lauder
Up to $5,000
Claims opening soon

A Canada-wide class action alleges Zantac makers concealed cancer risks linked to ranitidine, seeking refunds and damages.
The case concerns undisclosed cancer risks from ranitidine in Zantac products sold in Canada, with claims that manufacturers failed to warn consumers.
This class action targets manufacturers of Zantac and ranitidine generics for allegedly hiding cancer risks from consumers in Canada. The lawsuit seeks refunds, punitive damages, and other relief for those who purchased or ingested Zantac, which metabolizes into a probable carcinogen called NDMA.
Compensation pending
Claim deadline: Pending court decision
Estée Lauder
Up to $5,000
Claims opening soon

Keurig
Up to $50
5 days left
🔥 534 started this claim
Silk and Great Value
Up to $300,000
105 days left
Audible
Compensation pending
Claims opening soon
Government of Canada
Up to $200,000
755 days left

Meta (Facebook)
Up to $90
Claims opening soon